Friday, November 26, 2010

Medical News

Medical News


Anthracycline rechallenge feasible with pegylated liposomal doxorubicin

Posted: 25 Nov 2010 04:00 PM PST

Anthracycline rechallenge with pegylated liposomal doxorubicin provides clinical benefit to nearly 40% of patients with metastatic breast cancer who have previously received conventional anthracyclines, researchers report.

Statins reduce CVD risk in Chinese Type 2 diabetes patients by up to 50%

Posted: 25 Nov 2010 04:00 PM PST

Statins can reduce the risk for cardiovascular disease by 40–50% in Chinese patients with Type 2 diabetes, research suggests.

Statins reduce CVD risk in Chinese Type 2 diabetes patients by up to 50%

Posted: 25 Nov 2010 04:00 PM PST

Statins can reduce the risk for cardiovascular disease by 40–50% in Chinese patients with Type 2 diabetes, research suggests.

Intravenous insulin does not affect diabetic post-PCI inflammatory markers

Posted: 25 Nov 2010 04:00 PM PST

Intravenous insulin does not prevent rises in inflammatory or oxidative stress markers after percutaneous coronary intervention in patients with diabetes compared with standard insulin treatment, study findings suggest.

Anthracycline rechallenge feasible with pegylated liposomal doxorubicin

Posted: 25 Nov 2010 04:00 PM PST

Anthracycline rechallenge with pegylated liposomal doxorubicin provides clinical benefit to nearly 40% of patients with metastatic breast cancer who have previously received conventional anthracyclines, researchers report.

No comments:

Post a Comment